40537911000001100: Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\UK product\Virtual therapeutic moiety\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\UK product\Virtual therapeutic moiety\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing 5-hydroxytryptamine-3-receptor antagonist\Product containing ondansetron\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing 5-hydroxytryptamine-3-receptor antagonist\Product containing ondansetron\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing 5-hydroxytryptamine-3-receptor antagonist\Product containing ondansetron\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ondansetron\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ondansetron\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ondansetron\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiemetic agent (product)\Product containing ondansetron\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiemetic agent (product)\Product containing ondansetron\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiemetic agent (product)\Product containing ondansetron\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)\Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2027691000001114 Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2027701000001114 Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Has excipient	Benzyl alcohol	false	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Is a	Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)	true	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Has excipient	Aspartame	false	Inferred relationship	Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets	Has AMP	True	Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2027691000001114	Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2027701000001114	Ondansetron 8mg orodispersible tablets (Aristo Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module